Co-delivery of TAP siRNA and CpG ODNs to cDC1 inhibited tumor growth and exhibited superior antitumor activity than delivery of TAP siRNA alone in combination with CD40 Ab (Fig. 6). Here, CD40 is linked to neoplasm.